Patent · US Active

Methods and compositions for inducing protective immunity against a marburg virus infection

US10925956B2 · kind B2 · utility

0Cited by

5References

18Claims

0Family size

Assignees

Janssen Vaccines & Prevention B.V.
Bavarian Nordic A/S · DK

Inventors

Benoit Christophe Stephan CALLENDRET · The Hague, NL
Ramon Roozendaal · Utrecht, NL
Jutta Sytske Hartkoorn-Pasma · Leiden, NL
Ariane Volkmann · Andechs, DE
Robin Steigerwald · Munich, DE
Ulrike Dirmeier · Starnberg, DE

Key dates

Filing date	Jul 14, 2017
Grant date	Feb 23, 2021
Priority date	—
Expiry date	Jul 14, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/14271
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions, vaccines and methods using a combination of adenovirus vectors and MVA vectors for inducing protective immunity against a Marburg virus infection are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.